PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Guanylyl cyclase activation reverses resistive breathing-induced lung injury and inflammation.

Mouse / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25353067 ↗2015Reported benefit

Guanylyl cyclase activation reverses resistive breathing-induced lung injury and inflammation.

MouseOtherC57BL/6; soluble guanylyl cyclase alpha1 knockoutMalePrior administration for prevention; therapeutic administration 24 h after resi…

Model: Inspiratory resistive breathing produced by tracheal banding restricting tracheal surface area to 50% for 24 h

Soluble guanylyl cyclase activation with BAY 58-2667 prevented and, when given 24 h after resistive breathing, reversed the established lung injury, whereas sGC inhibition or sGC alpha1 deficiency exacerbated it.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.